Marta Alegret
Alegret i Jordà, Marta
VIAF ID: 305860882 ( Personal )
Permalink: http://viaf.org/viaf/305860882
Preferred Forms
-
100 1 _ ‡a Alegret i Jordà, Marta
-
100 0 _
‡a
Marta Alegret
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Activación de PP2A y alteraciones metabólicas inducidas por la ingestión de fructosa en forma líquida |
|
| Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs |
|
| Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization. |
|
| Aplicació de la carpeta d'aprenentatge a la universitat |
|
| Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages |
|
| Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. |
|
| Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4 |
|
| Cholesterol lowering and beyond: role of statins in Alzheimer’s disease |
|
| Cholesterol regulation of genes involved in sterol trafficking in human THP-1 macrophages. |
|
| Chronic fructose intake does not induce liver steatosis and inflammation in female Sprague–Dawley rats, but causes hypertriglyceridemia related to decreased VLDL receptor expression |
|
| Chronic Liquid Fructose, but not Glucose, Supplementation Selectively Induces Visceral Adipose Tissue Leptin Resistance and Hypertrophy in Female Sprague-Dawley Rats |
|
| Comentarios bibliográficos |
|
| Dabigatran etexilate: Another Double-Edged Drug? |
|
| Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits. |
|
| Different response of senescent female Sprague-Dawley rats to gemfibrozil and rosiglitazone administration. |
|
| Differential inhibition of long-chain acyl-CoA hydrolases by hypolipidemic drugs in vitro. |
|
| Efectes metabòlics, vasculars i cognitius del consum de sucres simples en rates femella |
|
| Efecto "in vivo" de los derivados fíbricos sobre enzimas microsomales implicados en la síntesis hepática de ácidos grasos |
|
| Effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits. |
|
| Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation |
|
| Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. |
|
| Estudio de alteraciones del tránsito intestinal |
|
| Etomoxir, Sodium 2-[6-(4-Chlorophenoxy)hexyl]oxirane-2-carboxylate, Up-Regulates Uncoupling Protein-3 mRNA Levels in Primary Culture of Rat Preadipocytes |
|
| Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. |
|
| Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. |
|
| Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe. |
|
| Gemfibrozil modifies acyl composition of liver microsomal phospholipids from guinea-pigs without promoting peroxisomal proliferation |
|
| Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice. |
|
| Impairment of Novel Object Recognition Memory and Brain Insulin Signaling in Fructose- but Not Glucose-Drinking Female Rats. |
|
| In vitro effect of clofibric acid derivatives on rat hepatic microsomal electron transport chains |
|
| Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats |
|
| Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice. |
|
| Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells. |
|
| Ingesta de fructosa líquida, fetge gras i intolerància a la glucosa |
|
| Inhibition of rat liver microsomal fatty acid chain elongation by gemfibrozil in vitro. |
|
| JTT-705 |
|
| Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha. |
|
| Leptin down-regulates peroxisome proliferator-activated receptor γ (PPARγ) mRNA levels in primary human monocyte-derived macrophages |
|
| Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats. |
|
| Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. |
|
| Liquid fructose supplementation in LDL-R−/− mice fed a western-type diet enhances lipid burden and atherosclerosis despite identical calorie consumption |
|
| Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. |
|
| Marcadores de síndrome metabólico: papel de fattty acid binding protein 4 (FABP4) |
|
| Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus. |
|
| Modulació farmacològica del contingut de colesterol i dels gens que regulen el seu transport i metabolisme en el macròfag |
|
| El monocito/macrófago como diana terapéutica en la aterosclerosis |
|
| Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment. |
|
| mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars |
|
| Opposite fates of fructose in the development of metabolic syndrome. |
|
| Papel de PP2A en el control de la expresión de PPARα por fructosa en células FaO de hepatoma de rata |
|
| Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs. |
|
| Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin. |
|
| Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. |
|
| Regulació de l'expressió gènica en monòcits/macròfags per factors pro-aterogènics modulació farmacològica |
|
| Regulation of gene expression in atherosclerosis: insights from microarray studies in monocytes/macrophages. |
|
| Resistencia a la leptina: eje MAPK-AMPK y fosforilación de STAT-3 en Ser727 en rata alimentada con fructosa |
|
| Ritonavir incrementa la expresión de CD36 y ABCA1 en macrófagos THP-1 |
|
| Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. |
|
| Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague–Dawley rats |
|
| Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight |
|
| Statins inhibit HIV-1 infection by down-regulating Rho activity. |
|
| Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. |
|
| Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages. |
|
| Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. |
|
| Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats |
|
| Uncoupling protein-3 mRNA up-regulation in C2C12 myotubes after etomoxir treatment. |
|
| Way back for fructose and liver metabolism: bench side to molecular insights. |
|
